Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube
    Most popular

    Latest News

    InnovHeart announces first-in-human use of its Saturn mitral valve

    Blood troponin level could predict silent heart disease risk

    St Jude Medical launches new Trifecta GT tissue valve in the USA

    First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place

    TAVI company Direct Flow Medical closes after failing to secure funding

    First report gives insight on impact of COVID-19 in heart transplant patients

    Half of COVID-19 patients receiving echocardiograms show heart abnormalities

    BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease

    One-third of critically ill COVID-19 patients in Washington State series developed cardiomyopathy

    Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients

    COVID-19: American Heart Association issue pandemic CPR guidelines

    The Foundry announces first-in-human procedure in study of Half Moon TMVR device

    TriGUARD 3 given CE mark for embolic protection during TAVI

    Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

    Duo device for tricuspid repair records first successful use in humans

    FDA approves the world’s smallest mechanical heart valve

    Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement

    Cardiovalve

    Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system

    No significant differences between Watchman and Amplatzer in first comparison

    Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease

    First 10-year report of TAVI durability indicates a low rate of structural valve deterioration

    “A huge loss to the cardiology community”: Tributes paid to Prof David Foley

    MitraClip in moderate surgical risk patients

    Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version

    STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve

    CMSS

    CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected

    Functional bicuspid aortic valves associated with improved outcomes compared with other morphology types

    Transcatheter heart valves are overlapping with coronary arteries

    AHA issues oxygenation and ventilation guidance for healthcare providers

    Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates

    STS 2021: Sean C Grondin elected STS president

    CPT code for CathWorks’ 3D FFRangio wire free system

    Siemens Healthineers to demonstrate remote capabilities of Corindus CorPath GRX robotic system using Mentice VIST simulator

    ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

    Edwards Lifesciences’ Alterra adaptive prestent device used for first time to treat a malformed pulmonary valve

    Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease

    STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery

    Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

    Latest statistics show heart failure on the rise

    PPE guidance for cardiology during COVID-19 pandemic operating in a “vacuum” in UK

    Michael Bohm

    Virtual ACC: Renal denervation bests sham control to safely lower blood pressure in patients with untreated hypertension

    TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation

    ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients

    Study suggests a more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

    PROACT clinical trial results published for On-X mechanical mitral valve

    TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial

    FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

    TAVI overtakes surgical aortic valve replacement in the USA

    PCR London Valves 2019: Meril unveils positive data for Myval

    Orsiro Mission DES

    Orsiro Mission gets CE mark

    Abiomed invests $15 million in Shockwave Medical

    Artificial intelligence could make endovascular aortic repair outcomes more predictable

    Blue Sail Medical and Biosensors International acquire TAVI company NVT

    Long-term exercise may lead to aortic enlargement and remodelling

    US physicians “among nation’s first” to implant neurostimulator technology for advanced heart failure

    Panel explores the unanswered questions around short duration DAPT

    Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic

    Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19

    BCIS and BCS ratify NHS guidance for cardiology during COVID-19 pandemic

    PCR London Valves 2019: TRILUMINATE shows safety and efficacy of TriClip maintained at one year

    Abiomed acquires novel ECMO developer Breethe

    Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation

    Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

    TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

    TCT Connect 2020: SOLVE-TAVI shows higher rate of stroke for balloon-expandable valve

    CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial

    Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

    xarelto rivaroxaban

    Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

    Philips integrates cloud-based AI and 3D mapping into its mobile C-arm system series

    CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality

    TCT MedTech Innovation Forum to spotlight opportunities for innovation

    TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients

    Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”

    ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction

    First-in-human “remote PCI” performed

    CE mark PASCAL clip-based system for transcatheter tricuspid repair

    First patient treated in study of PerQseal+ vessel closure device

    Miracor secures financing to support PiCSO clinical study

    VenusP-Valve

    VenusP-Valve gains CE mark

    PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

    ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy

    ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT

    ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures

    Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

    New England Journal of Medicine to review EXCEL data

    Xience Sierra approved for use in USA

    VDYNE secures funding for studies of tricuspid valve replacement device

    CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

    Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

    Machine learning may help identify people at risk of thoracic aortic aneurysm

    CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent

    Medtronic receives CE mark for 34mm size CoreValve Evolut R

    Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

    Corindus relocates Massachusetts headquarters to accommodate company growth

    PASCAL poised to rival MitraClip for safety and efficacy

    ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban

    Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients

    Medtronic names Laura Mauri as new chief scientific, medical and regulatory officer

    CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

    Miracor Medical’s PiCSO System receives CE mark

    ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

    Vesalio

    Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI

    FDA issues IDE for Impella ECP and EUA for Impella RP

    SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

    First-in-human implant of BeGrow stent performed in 24-day old baby

    Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

    First patient implanted with Intrepid TMVI device in APOLLO trial

    ACC.21: Digital app should replace stent cards as a patient PCI record

    Edwards Lifesciences to discontinue its self-expanding valve Centera

    Synthetic heart valves could help doctors improve surgical skills

    AATS and STS opt not to endorse joint coronary revascularisation guidelines

    Machine learning predicts 10-year risk of death in patients with suspected or known coronary artery disease 

    SCAI issues advice for cath labs in light of COVID-19 pandemic

    Daniel M Philbin Jr named new chair of the ACC board of governors

    Keystone Heart announces first case using TriGUARD 3 CEP device

    everolimus

    Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs

    COVID-19: European Commission looking to postpone new MDR by one year

    Cordis launches Mynx Control vascular closure device in the USA

    Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

    Tria

    Study backs biopolymer used in Foldax’s Tria valve

    ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years

    Italian boy becomes youngest patient bridged to transplant with the SynCardia Total Artificial Heart

    Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments

    Proximo Medical and Coala Life announce partnership for US markets

    Philips iFR Coregistration SyncVision

    Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray

    Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

    AHA 2022: First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients with high-quality great saphenous vein

    Tria

    First-in-human use of Tria biopolymer heart valve completed

    EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

    CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years

    NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

    CSI 2017: Global postmarket surveillance study to explore use of LAmbre LAA closure system

    Heart team approach points to mortality benefit in complex cardiac patients

    First patients treated with the Impella ECP heart pump

    FDA clears CavaClear IVC filter removal laser sheath

    Italy, USA and the UK share their cardiology COVID-19 experiences in LIVE Webinar

    Syntax Score website: A tool for the best strategy

    IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

    Philips expands cardiac ultrasound portfolio

    First patient enrolled in EXPAND TAVR II trial

    IVL

    Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

    COVID-19: Edwards pauses enrolment in mitral and tricuspid trials to allow hospitals to focus on virus

    FDA issues two final guidances for including patient perspectives in medical device studies

    TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve

    Abbott launches virtual reality training programme for cardiologists using OCT imaging technology

    CRT 2021: Polymer-free amphilimus-eluting stent non-inferior to zotarolimus-eluting stent in PCI patients

    Abbott becomes first company in world to have transcatheter mitral implantation device on market

    ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

    TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study

    Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

    Research reveals improved outcomes and decreased mortality in management of aortic dissections with care plans designed by multidisciplinary expertise

    Cardiologists share COVID-19 insights

    coronary artery bypass

    Virtual ACC: Use of radial artery in heart bypass surgery improves patient outcomes

    Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure

    PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement

    First coronary patient enrolled in FDA IDE study of drug eluting balloon

    TMVI with Tiara valve may be safe and feasible for patients with prior aortic valve replacement

    SafeCross transseptal balloon gets first commercial use

    SCAI 2020: PROTECT III shows placing Impella prior to high-risk PCI associated with lower mortality

    CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition

    TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

    PCI for chronic total occlusion less successful after bypass surgery

    Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems

    Vivasure Medical announces Series D financing to advance portfolio of PerQseal vessel closure devices

    Prolonged TV watching may increase risk of venous thromboembolism

    ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

    New technique outperforms manual assessment of thoracic aortic aneurysm growth

    PERT Consortium and BTG form strategic partnership

    CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations

    FDA approves Evolut PRO+

    UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

    EXCEL finds repeat revascularisations following both CABG and PCI lead to increased mortality

    Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

    Analysis of LAA closure devices reveals post-approval spike in safety events

    Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

    New publication “extends evidence for clinical benefit” with CytoSorbents’ haemoadsorption technology into type A dissection aortic surgery

    Cardiothoracic surgeons are “extremely satisfied” with their jobs

    TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

    ESC 2021: One-month dual antiplatelet therapy post-stent implant benefits high bleeding risk patients

    Lab-grown heart valves capable of growth in recipient, research finds

    PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study

    Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes

    First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system

    Polymer-free stents have similar performance profiles, except in diabetes

    Tria

    First clinical results for Tria biopolymer valve published

    Edwards Lifesciences acquires Harpoon Medical

    Harpoon Medical acquired by Edwards

    BioCardia gets FDA clearance for catheter to guide Helix delivery system

    Cardiovascular Systems

    First patient treated with Cardiovascular Systems’ ViperCross peripheral support catheter

    Heart team approach central to updated coronary revascularisation guidelines

    Xience Sierra is now on European market

    Decreased ACE2 levels found in ageing and cardiovascular disease can increase likelihood of severe COVID-19

    FDA Breakthrough Device Designation for fully implantable left ventricular assist system

    SCAI 2020: Strong 10-year performance for Melody transcatheter pulmonary valve

    STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI

    FDA approval granted for Mitris Resilia mitral valve replacement

    Keith Oldroyd to become CMO at Biosensors

    Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched

    MedAlliance gains CE mark for coronary Selution SLR sirolimus drug eluting balloon

    Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial

    Jeffrey J Popma joins Medtronic as vice president and chief medical officer for coronary, renal denervation, and structural heart businesses

    First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

    CE mark for transcatheter system that uses same clip technology as MitraClip

    Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability

    Corresponding author Evald Hoj Christiansen

    NOBLE finds PCI inferior to CABG at five years in left main disease

    Woman patient

    COVID-19: Nearly 40% drop in STEMI cases in US cath labs since March 2020

    TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI

    India-designed Myval associated with no device-related mortality at one year

    Augmented reality surgical technology unveiled by Philips and Microsoft

    STS 2021: Cardiothoracic surgery suffers due to COVID-19

    Abiomed gains approval for data streaming from the Impella console

    PCR LV 2018: Early discharge feasible for unselected TAVI patients

    EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

    First implant of MonarQ tricuspid valve replacement system performed in Copenhagen

    EuroPCR 2021: Late-breaking data demonstrate long-term benefits of Medtronic radiofrequency renal denervation in real-world hypertensive patients

    TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3

    Gore buys transcatheter mitral chordal repair technology

    Supreme drug-eluting stent “safe and effective” in complex coronary lesions

    Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

    EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent

    Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients

    PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”

    A higher volume of mitral valve repair procedures is associated with lower mortality rates

    SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

    HeartFlow enters into licensing agreement with Cedars-Sinai for AutoPlaque technology

    Robocath completes European study of robot-assisted PCI

    Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro

    TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs. Orsiro

    Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR

    EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

    Death due to cardiovascular disease more likely among Black adults born in the USA

    impella in preventing heart failure in stemi patients

    New trial to evaluate role of Impella in preventing heart failure in STEMI patients

    stroke risk factors

    ESOC 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women

    Live webinar on Thursday 2 April to share COVID-19 cardiovascular experience

    First United States treatment with J-Valve TAVI device

    Shockwave commences IVL study to support regulatory approval in Japan

    CRT 2020: TAVI safe at 30 days in low-risk bicuspid aortic stenosis

    Medtronic launches Onyx Frontier coronary stent following CE mark approval

    Medtronic expands reach of AI-powered surgical video management and analytics platform

    ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function

    CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial

    Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy

    New performance and quality measures for treating heart attack patients

    Next-generation Watchman LAAC device gains US FDA approval

    EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

    CSI’s Propel pVAD system gets first-in-human use

    New AHA/ACC guidance released for TAVI

    TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients

    MitraClip in moderate surgical risk patients

    Next-generation of MitraClip approved for use in the USA

    PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients

    Patient-specific, 3D printed aortic valve model used in preparation for TAVR procedure

    Medtronic stops sale of its HVAD system

    Young surgeons to benefit from Transatlantic grant scheme

    TARGET BP I trial enrols its first patient

    SonieVie

    SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology

    TCT 2017: No role for bare metal stents to reduce duration of dual antiplatelet therapy in older patients

    PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device

    Tria

    Foldax commences clinical study of Tria surgical aortic valve in India

    TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

    MitraClip in moderate surgical risk patients

    Draft NICE guidance supports use of percutaneous mitral valve repair

    PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI

    VISION study concludes troponin is a benchmark for cardiac surgery risk

    Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US market

    CE mark granted to NVT for Allegra transcatheter aortic valve

    NICE issues recommendations on insertion of cerebral protection devices during TAVI

    First US implantations of TriCinch Coil tricuspid valve repair system performed

    PCR LV 2018: One-year results of VIVA confirm safety and efficacy of valve-in-valve procedures with CoreValve

    New guideline: ASA no longer recommended to prevent first stroke, heart disease

    Resolute Onyx matches Orsiro at two years in all-comers’ patients

    CryoLife given CE mark for On-X Ascending Aortic Prosthesis

    Meta-analysis shows FFR-guided PCI reduces myocardial infarction

    Zip surgical skin closure device associated with less pain for paediatric patients undergoing congenital heart surgery

    COVID-19: European Commission agrees to postpone new MDR because of pandemic

    Halting methamphetamine abuse can reverse related heart damage

    ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19

    The British Heart Foundation’s “Big Beat Challenge” is now accepting proposals

    Deep learning tool could predict future myocardial infarction

    Two further studies support three-month DAPT following PCI

    BTG buys Novate Medical

    Onyx One Clear Study

    Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

    Abbott to acquire Cephea Valve Technologies

    “Worrisome” rise in cardiovascular disease predicted out to 2060

    ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients

    Women underrepresented in cardiovascular clinical trial leadership positions

    AHA 2020: One-month DAPT safe and feasible after stent placement

    SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients

    Teleflex buys vascular closure company Essential Medical

    ACS defends healthcare workers as PPE shortages lead to acrimony

    Bolus version of Aggrastat is now approved in the USA

    Medtronic’s Resolute Onyx approved for one-month DAPT labelling by US FDA

    ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

    First US patient treated in trial of Harpoon mitral valve repair system

    Sapien 3

    Sapien 3 with Alterra prestent gains FDA approval

    Abiomed announces PROTECT III clinical data for protected PCI with Impella

    SCAI 2021: ISCHEMIA trial population not reflected in real-world patients

    Philips launches Ultrasound Workspace at ACC.22

    CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

    VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions

    Woman patient

    Black patients have higher rates of death after PCI

    AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

    FEops Heartguide receives FDA clearance for LAAO planning capabilities

    FDA approves coronary use of XO Cross support catheter system

    EXCEL: PCI inferior to CABG in Bayesian reanalysis

    MicroPort obtains CE mark for PathBuilder

    PERSIST-AVR study on Perceval sutureless aortic valve presented at AATS

    CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

    ESC 2019: Registry study supports use of ICDs for primary prevention in patients with heart failure

    Robocath announces completion of first robotic coronary angioplasty with R-One in China

    coronary artery bypass

    Meta-analysis supports use of all-cause mortality in PCI versus CABG trials

    US FDA approve SSO2 Therapy for the management of myocardial infarction

    virtual stroke care

    Stroke and heart condition patients want virtual healthcare to continue post pandemic, surveys indicate

    InnovHeart appoints Brent Ratz as independent member of the board

    Abbott initiates trial focusing on twin AF and heart failure treatments

    Venus Medtech announces Cardiovalve acquisition

    ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI

    ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients is not safe

    FDA approves new device to improve symptoms in patients with advanced heart failure

    impella in preventing heart failure in stemi patients

    FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps

    Virtual ACC: Genotype-guided therapy after PCI does not hit study target

    SCAI updates consensus guidelines on cath lab standards

    EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

    Medtronic gains FDA approval for its latest-generation TAVI system

    EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

    viz series d

    Viz.ai raises US$100 million in Series D funding to expand AI technologies

    ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event

    TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

    TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

    ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care

    Caution needed for TAVI in younger, low-risk aortic stenosis patients

    On-pump and off-pump CABG confer similar outcomes over 10 years

    FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic

    wirion

    Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

    Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

    Guy’s and St Thomas’ to merge with Royal Brompton & Harefield NHS Foundation Trust

    ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery

    ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

    HeartFlow submits premarket application for coronary plaque assessment

    First-in-human study paves way for further clinical trials of Valvosoft

    PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI

    PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion

    SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

    Translumina announces launch of dual drug polymer-free coated stent

    PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via a transseptal approach

    “Game changing” photon-counting CT system arrives at John Radcliffe Hospital

    New study elucidates exact location of atherosclerotic plaque ruptures in carotid arteries

    Evolut PRO TAVI valve gains approval in China

    New JACC publication reinforces valve of a coronary CTA + HeartFlow Analysis-guided pathway for diagnosing heart disease

    CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT

    AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

    PCI procedures drop by 10% in USA since 2010, research suggests

    SCAI names Timothy Henry as president

    ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

    COVID-19: US societies release joint consensus statement on treating myocardial infarction during the pandemic

    EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

    Cardiovascular News’ top 10 most popular stories of February 2022

    Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients

    Sapien 3

    Launch of Sapien 3 Ultra hampered by Boston Scientific dispute

    Medtronic’s Evolut PRO+ TAVI system gains CE mark

    Transcatheter repair of tricuspid valves appears safe and effective when surgery is not an option

    AHA 2018: Early invasive strategy without pretreatment significantly reduces recurrent ischaemic events in NSTE-ACS patients

    EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

    New valvular heart disease guidelines recognise expanding role of TAVI

    TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve

    Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

    Nonagenarians should not be denied TAVI based solely upon age

    Ancora Heart receives IDE approval for study of AccuCinch

    Caption Health and Ultromics partner to increase availability of heart disease detection and management tools 

    EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

    10-year data on VIVO ISAR drug-eluting stent published in JACC

    Cardiovascular News’ top 10 most popular stories of April 2022

    Admedus sells CardioCel and VacsuCel to focus on TAVI

    Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe

    Cordis granted CE mark for Railway sheathless access system

    ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients

    EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system

    Meril Life Sciences’ Biomime sirolimus-eluting stent receives the CE mark

    ageing mitral valve surgery

    Frailty predicts greater death rate and higher costs after mitral valve surgery

    Shockwave completes enrolment in study of coronary intravascular lithotripsy

    Philips launches IntraSight interventional applications platform

    Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

    ACC 2017: “iFR may be the new standard” of physiological assessment of coronary lesions

    FDA approves world’s first device for treatment of premature babies and newborns with an opening in their hearts

    Teleflex catheters and coronary guidewires cleared for CTO PCI

    Positive results for LivaNova’s Perceval sutureless valve

    First 1,000 patients treated with Impella 5.5 with SmartAssist

    “Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

    Medtronic begins early feasibility study of the Intrepid transcatheter valve system

    PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair is sustained at one year

    Coronary artery modelling technology enables 3D reconstruction of coronary vasculature

    Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas

    Shockwave’s coronary IVL device gains TPT payment approval

    First patient implanted with next-generation AngelMed Guardian system

    TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

    FDA sends letter warning about mortality and risks with the Syncardia TAH-t Companion 2 Driver

    Perceval sutureless valve data presented at EACTS 2020

    More experienced TAVI centres “less likely to use heart team approach”

    ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

    AHA 2016: Heparin plus tirofiban is safe and effective for use during PCI

    BBC Newsnight makes fresh claims about allegedly withheld mortality data in EXCEL

    Lotus Edge becomes third TAVI device on US market

    MedAlliance launches Origin balloons for vessel preparation

    Chronic kidney disease should not be a barrier to TAVI

    Hormone therapy linked to heart fat and hard arteries

    Neurescue’s aortic occlusion device gains US FDA approval

    Bioventrix announces positive one-year outcomes for Revivent TC system

    Realview Imaging gains FDA approval for Holoscope-i system

    Medtronic HeartWare HVAD approved for destination therapy

    Does your insurance card matter when you have a heart attack?

    Mardil Medical completes treatment of third patient in VenTouch device trial

    AI-guided cardiac imaging system given FDA authorisation

    First-in-human results of Captis embolic protection device presented at EuroPCR 2022

    TCT 2022: Amulet occluder keeps pace with Watchman at three years

    CE mark granted to the Gore Cardioform ASD Occluder for the treatment of atrial septal defects

    SyMap Medical closes US$100 million financing round

    AHA 2020: Patients taking statins experience similar side effects from placebos

    Virtual ACC: Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularisation

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of November 2021

    STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president

    Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ

    AHA 2020: AF detected more often in high risk patients recovering from cardiac surgery

    TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

    FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

    Boston Scientific closes acquisition of Baylis Medical Company

    VersaCross RF Transseptal device found to be efficient for TMVR procedures

    Health Canada approves a high-dose bolus regimen of tirofiban

    Puzzle Medical wins 2022 TCT Shark Tank innovation competition

    Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

    Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

    FDA approve TSP Crosser transseptal access system

    ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients

    LivaNova reaches agreement to sell its heart valve business

    Biosensors gains CE mark approval for BioFreedom Ultra stent system

    Boston Scientific to buy cerebral protection system company

    Next-generation troponin T test from Roche cleared by US FDA

    AHA 2018: Pilot study paves way for future evaluation of delaying reperfusion in STEMI patients

    PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure

    ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

    Mehran TCT 2020

    TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens

    Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial

    EuroPCR 2022 hears new data on robotic PCI

    EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

    AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease

    High coronary artery calcium score increases risk of heart attack or stroke

    AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis

    Latest TRILUMINATE and TRI.Fr data add to growing body of evidence for tricuspid TEER

    Sildenafil-coated stent may help prevent blood clots and restenosis

    Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients

    First patient enrolled in US arm of ALIVE pivotal clinical trial

    Sapien 3

    Sapien 3 Ultra receives FDA approval

    AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

    Venus Medtech to buy cerebral protection device company Keystone Heart

    Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails

    Woman patient

    Women wait for longer before calling for help when experiencing heart attack symptoms

    SCAI issues position paper on transaxillary arterial access

    Boston Scientific announces positive PINNACLE FLX study results

    Abbott’s Navitor TAVI system receives CE mark

    Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients

    American College of Cardiology names its first director of diversity and inclusion

    “Remote PCI” successfully performed 100 miles away from the cath lab

    ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial

    FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

    Japanese and US regulatory approvals granted for BioFreedom stent

    Medtronic launches Telescope guide extension catheter

    Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death

    Append Medical completes transcatheter implant-free LAA occlusion procedures

    Enrolment completed for MASTER DAPT trial

    Bayer announces new licensed indication for use of Xarelto in patients with coronary artery disease

    Mavacamten granted US FDA new drug application

    ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published

    Enrolment in FAST-FFR trial completed early

    ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG

    ACC.21 late-breaking clinical trial programme announced

    First patient enrolled in PROTECT IV randomised controlled trial of Impella

    ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience

    Xience stent receives CE mark for short duration DAPT

    Research suggests many patients may be safely discharged without opioids after cardiac surgery

    MedAlliance announces first patient enrolment in SELUTION DeNovo study

    PCR Valves: “Encouraging” early results from DragonFly transseptal mitral valve presented

    Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation

    OPN NC “super-high-pressure” coronary balloon launches in USA

    Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

    IN.PACT Falcon drug-eluting balloon yields positive outcomes

    Wearable necklace-ECG can detect abnormal heart rhythm

    Research finds poor level of surveillance following aortic dissection repair

    AHA 2018: Efficacy and safety of PCI with Ti-no coated bio-active stents presented

    Medtronic Canada completes end-to-end remotely-guided TAVI procedure

    Cardiovascular robotics company secures €40 million series C financing round

    Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn

    MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

    Cardiovascular News’ top 10 most popular stories of March 2022

    ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may be on the cards

    PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation

    EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

    Patent granted to Valfix Medical for its percutaneous valve and replacement technology

    London’s Science Museum honours 50 years of heart transplants

    Robotic PCI associated with a 20% reduction in radiation exposure

    ACC launches summer COVID-19 education series

    AI

    AI-based algorithm could predict outcomes after cardiac surgery

    Past, present and future of cardiovascular innovation celebrated at Global Cardiovascular Awards

    ESC 2018: Cardioskin launched

    Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

    Medtronic releases Resolute Onyx drug-eluting stent in Japan

    NuVera announces successful first-in-human use of NuVision ICE catheter

    “Cuffless” system to monitor blood pressure could replace traditional methods

    Partnership to promote wearable tech in cardiology trials

    “Low commercial sales” prompt Abbott to pull the plug on selling Absorb

    ESC 2019: Abiomed launches Impella SmartAssist platform

    Revivent transcatheter system receives Breakthrough Device Designation from the FDA

    SCAI pushes revised standardised language to improve cardiogenic shock care

    ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS

    Vascade vascular and venous closure devices gain CE mark

    Evolut gets CE mark in low-risk patients and new labelling for bicuspid use

    Aktiia’s wrist-mounted blood pressure monitor gains CE mark

    CeloNova to seek medical device partnerships

    AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI

    Transcatheter tricuspid valve replacement “low risk” for complications

    LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

    Cordella pulmonary artery pressure sensor reaches 100-implant milestone

    RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

    EuroPCR 2021: Meta-analysis supports elective coronary revascularisation

    SCCT releases new guideline for use of computed tomography in TAVR procedure

    EACTS 2022: “Wake up call” for trialists over gender balance

    Shockwave initiates US pivotal study for coronary intravascular lithotripsy

    Analysis charts “significant” growth of US TEER procedures since 2012

    TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold

    Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

    Cathy Gates named as ACC’s new CEO

    AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes compared with HeartMate II LVAD

    Adapt clinical studies to alleviate effect of pandemic

    Results from EXTRACT-PE trial of Penumbra’s Indigo aspiration system published

    CroíValve completes funding round for study of Duo system

    First European patient treated with Diamondback 360 coronary orbital atherectomy system

    EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time

    EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold

    Study of CorWave’s LVAD presented at ASAIO annual meeting

    Tria

    CRT 2022 hears results of animal study of Tria TAVI valve

    Edwards lifesciences launches physio tricuspid heart valve repair ring

    American Academy of Neurology recommends PFO closure for selected stroke patients

    Restore Medical announces preliminary results from first-in-human use of ContraBand

    Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change

    Gore’s Cardioform Septal Occluder reaches 10-year milestone

    iVascular announces 6mm maximum overexpansion capacity for Angiolite DES

    iVascular acquires 10% of NaviGate Cardiac Structures for US$10 million

    Corindus completes first transcontinental simulated telerobotic PCI procedures over 5G, fibre, and public internet networks

    Bicuspid TAVI outcomes as good as those for tricuspid

    Medtronic enters into AI partnership for stroke care

    STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery

    Abbott’s HeartMate 3 LVAD receives approval for paediatric use

    ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling

    FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

    Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

    Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease

    Tributes paid following death of esteemed UK cardiologist Anthony Gershlick

    ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI

    TVT 2018: Positive results for Manta large bore closure device

    Virtual ACC: Clopidogrel exposure along with aspirin and rivaroxaban should be “minimised or avoided” in PAD revascularisation

    Next generation TriClip gains CE mark approval

    Shockwave coronary IVL gains Japanese approval

    ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial

    The European Commission authorise use of evolocumab to reduce risk of myocardial infarction in patients with established cardiovascular disease

    TAVI-induced bundle branch block and permanent pacemaker implantation are “not benign”

    Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes

    MDR comes into effect across EU

    Heart Research UK awards grant to University of Leeds to develop new heart failure treatments

    TCT 2022 hears “important data” from renal denervation trials

    First patient enrolled in phase II of REFLECT study of TriGuard 3

    CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era

    Age alone should not preclude TAVI in patients aged ≥90 years

    COVID-19: Mayo Clinic works with Ultromics to rapidly assess patients with COVID

    JenaValve Technology appoints John T Kilcoyne as chief executive officer

    Megha Prasad selected as SCAI-Women in Innovations CHIP Fellowship

    Expert group sets out principles for device-led hypertension trials

    Onyx One Clear study starts in USA and Japan

    EuroPCR 2018: Positive data for renal denervation reignites interest in field

    Implantation of JenaValve successful in initial patients enrolled in CE mark study

    Survival benefit of early intervention in non-STEMI patients is independent of other factors

    COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

    PCR London Valves 2019: One-year survival better with Mitra Clip than with medical therapy among COAPT-excluded patients

    NICE lowers threshold for statins to prevent cardiovascular events

    Results from Onyx One Clear study published

    Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

    Patients “fearful” of seeking cardiac care during pandemic

    Diamondback 360 atherectomy system gains CE mark

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of March 2021

    AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor

    EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month DAPT study

    “Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at one year

    Findings of meta-analysis “move the conversation forward” on left main revascularisation

    Boston Scientific discontinues Lotus Edge TAVI device

    Smartphone app uses can identify lung congestion in heart failure patients

    ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents

    COVID-19: Survey suggests increased operating days may be required to clear elective backlog

    Cardionovum’s coronary DCB receives regulatory approval in China

    Abbott receives CE mark for FlexNav delivery system

    PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective

    US launch for Abbott’s Ultreon AI-based coronary imaging platform

    “Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation

    First-in-human implants of Caisson Interventional’s percutaneous mitral valve device performed

    JIM 2020: Weigh up early and late events in EXCEL to determine treatment for left main disease

    AMA issues unique Category III Current Procedural Terminology codes for HeartFlow FFRct

    remote monitoring

    FDA approves Abbott heart pump for less invasive surgical approach

    Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

    Fourth-generation MitraClip receives FDA approval

    REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical thrombectomy for PE treatment

    STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery

    Keith Dawkins appointed as chief medical officer at Shockwave Medical

    Japanese study finds high survival rates with use of Impella heart pump

    AI improves confidence in CAD detection from a stress echocardiogram

    ACC to tackle patient, provider access to novel therapies

    Health Canada approval granted for SavvyWire TAVI guidewire

    Biotronik

    Biotronik appoint company’s first chief medical officer

    Robotic PCI company adds interventional cardiology experts to its medical advisory board

    First patient enrolled in COSIRA-II trial of Neovasc Reducer

    ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin

    Announcing the TCT 2019 late-breaking trials and science

    AHA 2022: SPYRAL HTN-ON MED study demonstrates “meaningful clinical benefits” consistent with other renal denervation trials

    ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

    China’s first human implantation of a retrievable TAVI device successfully completed

    AngelMed launches its Guardian device in the USA

    merit-medical-radial-compression

    Merit Medical unveils PreludeSYNC EVO radial compression device

    TCT 2018: Use of Impella in cardiogenic shock patients associated with relative 24% increase in survival

    Second myocardial infarction twice as likely to occur non-culprit artery than in culprit artery

    CE mark for CoreValve Evolut Pro

    COVID-19: FDA authorise blood purification device for treating virus

    Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery

    ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

    Zoll Medical acquires TherOx

    Initial implants of Thubrikar TAVI system to commence

    Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into clinical practice

    First two US patients receive Trisol tricuspid valve

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of January 2022

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of December 2021

    Malnourished patients have a three-fold risk of mortality after aortic valve replacement

    First patients enrolled in FAST III study of vFFR-guided PCI

    Multiphase and early systolic phase CT screening in TMVR superior to end systole analysis at predicting obstruction risk

    Adept announces Prone Support product launch

    Philips Minicare I-20 handheld devices receives CE mark

    Elunir drug-eluting stent approved for use in the USA

    SCAI launches web section devoted to COVID-19 updates and cancels Scientific Sessions

    First trial of in-heart micro device for left atrial pressure monitoring launched

    TCT 2017: Advances in device technology needed to improve outcomes with Absorb

    FDA approves Cardioform ASD Occluder for the treatment of atrial septal defects

    HeartFlow and Longview terminate merger agreement

    Stress testing can guide patient selection for coronary revascularisation

    LivaNova completes initial divestiture of its heart valve business

    First procedure performed in SMART head-to-head TAVI study

    New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines

    Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications

    Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

    Swedish registry data point to survival benefit for younger patients undergoing CABG

    TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart

    SCAI issues updated expert consensus statement on cardiogenic shock

    COVID-19: NHS staff show signs of mild depression

    Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

    CADILLAC risk score could be used to identify STEMI patients for safe, early discharge

    PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI

    FDA issues update on reducing the risk of patient infections during cardiac surgery

    ESC 2018: Positive one-year results for Interatrial Shunt Device

    Medtronic releases DxTerity diagnostic catheters and transradial approach tool

    EACTS 2020: surgeons told to be wary of “creeping” rise of TAVI

    TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation of transcatheter heart valves “safer and more efficient”

    heart attack

    NICE recommends new treatment to reduce stroke and heart attack deaths

    complete-revascularisation

    First patients treated with Aortix pMCS device

    AcQCross transseptal crossing devices gain US FDA clearance

    Depression significantly increases mortality after aortic valve replacement

    TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

    ESC 2018: More evidence that FFRCT is an effective approach for identifying patients who do not require further intervention

    First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

    COVID-19: Both ACC and ESC urge patients to seek help if they experience symptoms of a myocardial infarction

    AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves

    PreludeSync distal compression device now available globally

    First patient treated in HEAL-IST clinical trial

    Melody pulmonary heart valve receives FDA approval for valve-in-valve use

    ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI

    FDA approval for Viola clampless proximal anastomosis device

    EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and conventional angiography for revascularisation decisions

    Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of February 2021

    JenaValve receives FDA approval for expanded IDE enrolment in the treatment of patients with severe aortic stenosis and severe aortic regurgitation

    JIM 2022 moves to June slot

    Delaying CABG after AMI may not improve outcomes

    US FDA approves PK Papyrus stent for coronary perforations

    Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter

    Venus Medtech targets European growth with senior appointment

    Latest Sapien TAVI valve features anti-calcification technology

    Stephan Windecker (left) presents one-year outcomes from the TRISCEND study

    TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation

    Researchers find new carotid body-removal treatment for hypertension

    CONFORM pivotal trial of CLAAS system begins enrolment

    ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events

    Ultrasound guidance “should be routine” for transfemoral TAVI access

    TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery

    Sapien 3

    Sapien 3 valve approved for treatment of severe symptomatic aortic stenosis in Canada

    Low albumin, anaemia, and slow walking speed predict mortality after TAVI

    FDA approves Orsiro for use in the USA

    Germany renews Revivent’s NUB reimbursement status 1 for 2020

    TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

    Philips launces Azurion with FlexArm to aid image-guided procedures

    Sapphire II PRO becomes US’s first and only 1mm coronary balloon

    CABG shows 10-year benefit over PCI in left main patients with high SYNTAX score

    Cardiothoracic surgery “stifled” during COVID-19 pandemic

    Edwards Life sciences initiative

    Edwards expands its Every Heartbeat Matters initiative

    EMPOWER trial to study Carillon mitral contour system

    Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients

    Interim REVERSE-IT trial results published in NEJM Evidence

    ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

    Female acute myocardial infarction patients experience worse outcomes when treated by male physicians

    TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems

    RADIANCE-II renal denervation trial completes enrolment

    ESC 2021: Systematic pressure wire assessment has no additional benefit at diagnostic angiography

    TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients

    Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB

    Pioneering pig to human heart transplant heralded as a breakthrough

    FDA approval of 34mm CoreValve Evolut R means device is largest available TAVI valve in USA

    Douglas Drachman named as next vice chair of American College of Cardiology’s Annual Scientific Session

    AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI

    Abiomed introduces third generation Impella CP heart pumps at SCAI 2017

    Internationally renowned cardiac surgeon joins University of Miami Health System

    Looks do matter—patients claim what doctors wear is important

    Append Medical share clinical proof-of-concept results for internal sealing of LAA

    EXCEL leadership refute BBC Newsnight claims in 3,500-word document

    HeartWare HVAD system receives US FDA approval

    US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device

    Women 50% more likely than men to be given incorrect diagnosis following heart attack

    ACC 2017: FDA approves launch of CoreValve Evolut Pro

    EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”

    US trial of Edwards’ self-expanding Centera valve begins

    TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients

    FFRangio system receives US FDA clearance

    4Tech appoints Michael Ennen as president and chief executive officer

    Enrolment completed in US pivotal clinical study of Cardioform ASD Occluder

    Hospitals without high-level designation more likely to miss strokes following TAVI procedures

    PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus

    Proximo Medical to partner with CeloNova Biosciences

    “Neurocardiologists” could treat acute ischaemic stroke patients when a neurointerventionalist is not available

    Open Stent Solution closes €2.5 funding round

    ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality

    ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations for its PleuraFlow system

    Stem cell plasters “could revolutionise treatment of congenital heart disease”

    TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT

    App launched to cut time to treatment for STEMI patients

    ESC to stream the latest science in heart failure

    Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor

    Data for NobleStitch EL suture based closure system presented at CSI UCSF Congress

    SonieVie

    ESC and EAPCI publish renal denervation consensus statement

    Urgent action needed to address growing burden of heart failure

    Meta-analysis advocates “personalised approach” to DAPT duration after PCI

    US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of September 2021

    Sleeping less than six hours a night may increase cardiovascular risk

    Medtronic agrees to invest in TMVr device development

    COVID-19: Testing for high-sensitivity cardiac troponin would be beneficial not a hindrance

    Virtual ACC: Low-dose colchicine after myocardial infarction is “economically dominant”

    Medtronic announces global registry of HVAD thoracotomy implants

    Corindus rebrands to Siemens Healthineers Endovascular Robotics

    FDA approves Promus Element Plus and Promus Premier coronary stent systems

    AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

    EBBINGHAUS trial shows non-inferiority of evolocumab for cognitive function in cardiovascular group

    Review looks at TAVI device selection and concludes head-to-head studies needed

    Boston Scientific launches Acurate neo2 aortic valve system in Europe

    EU patients enrolled in REVERSE-IT trial of bentracimab for reversal of antiplatelet effects of ticagrelor

    Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter

    ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI

    First patient enrolled in PICSO-AMI-V study

    Atrial fibrillation related to PFO closure occurs early and is transient

    CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years

    Promising results for RenalGuard in heart failure patients

    Approval allows use of single access Impella procedure across Europe

    Corindus’ stockholders approve acquisition by Siemens Healthineers

    Boston Scientific closes Symetis acquisition

    Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

    First remote robotic-assisted PCI completed in Europe using R-One platform

    German NUB Status 1 designation for Neovasc Reducer renewed

    TVT 2018: Tiara TMVI device featured in live case

    STS 2020: Enhanced surgical recovery protocols will allow safe three-day discharge

    HeartFlow initiates PRECISE randomised clinical trial

    US FDA approval for Abiomed’s Breethe OXY-1 system

    FDA approves St Jude Medical’s PressureWire X guidewire

    Virtual ACC: Combining aspirin with rivaroxaban provides greater absolute risk reduction in diabetes

    Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

    Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI

    Philips and the US government collaborate in ventilator production ramp up to combat COVID-19 pandemic

    PCRLV 2016: New approaches to TAVI are still being explored

    Xience stent receives US FDA approval for short-duration DAPT

    TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial

    EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR

    TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

    LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke

    Alvimedica receives CE mark for amphilimus-eluting Cre8 EVO stent

    TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures

    TCT 2017: Elixir reveals new drug-eluting stent

    “Considerable” reduction in PCI-related radiation reported in last decade

    Edwards Lifesciences to collaborate with Bay Labs to use AI software to improve detection of heart disease

    ESC 2021: TOMAHAWK trial does not support early coronary angiography in cardiac arrest without ST elevation

    “Excellent early patency rates” for VEST device

    CE mark for R-One robotic-assisted solution for treating coronary diseases

    Left atrial appendage closure associated with a decreased stroke risk in AF patients

    Biotronik announces positive data for Magmaris

    paclitaxel

    Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg

    InnovHeart completes funding round to advance Saturn TMVR system

    US FDA approve EchoMD AutoEF software for calculating left ventricular ejection fraction

    Infraredx launches Makoto intravascular imaging system and Dualpro IVUS+NIRS catheter in Japan

    Carmat sets date for resumption of implants of artificial heart system

    Medtronic launches Contour 3D Annuloplasty Ring for the treatment of tricuspid valve disease

    EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

    Single-use, high-definition, miniature camera unveiled at Asia Pacific MedTech Forum 2018

    New literature review highlights that Perceval sutureless aortic valve is safe

    More than 100,000 people now know hands-only CPR thanks to AHA programme

    No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months

    Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System gets the CE mark

    Two-year results of mitral valve repair using ChordArt device published

    Mentice and Siemens Healthineers aim to bring a virtual patient to the angio-suite

    Orodispersible tablets of ticagrelor now available in the UK

    FARXIGA meets primary endpoint in Phase III DAPA-HF trial

    Why high pressure postdilatation with non-compliant balloons is required to optimise long-term DES outcomes

    EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

    Recurrent heart attacks declining, but overall rate remains high

    ESC 2022: High-risk aortic stenosis could be picked up using AI

    Sinomed announces the first commercial implantation and European launch of the HT Supreme DES

    First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

    COMPASS study of rivaroxaban to end early for efficacy

    SCAI 2020: Statin therapy plus icosapent ethyl significantly reduces number first and repeat revascularisation

    Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

    SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

    Emboline completes enrolment in SAFEPASS 2 clinical trial

    ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD

    ESC 2021: Study charts impact of following health advice after a heart attack

    ACC makes senior staff appointments

    Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials

    Boston Scientific closes acquisition of Claret Medical

    Machine learning model provides improved cardiac risk predictions compared to “gold-standard” STS scoring

    Quidel receives CE mark for its TriageTrue high sensitivity troponin I test

    Quest International and CathWorks partner to scale up FFRangio

    PCR London Valves hears first results from NeoChord Nexus mitral repair device

    TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings

    STS says independent analysis of EXCEL is best opportunity to “get it right for patients”

    EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

    First Revivent TC ventricular enhancement procedure for ischaemic cardiomyopathy performed

    COVID-19: ESC Congress 2020 to become a completely virtual event

    SIS Medical to launch three innovative balloon catheters

    Robert Califf to return as US FDA commissioner

    Early treatment with Helix system improves ejection fraction and symptoms

    Medtronic receives FDA approval for Harmony transcatheter pulmonary valve

    Advantage of guided de-escalation of dual antiplatelet therapy seen in younger patients

    AHA 2016: Two thirds of patients experience plaque regression with the PCSK9 inhibitor evolocumab

    ACC.21: Apixaban not superior to standard of care following TAVI

    complete-revascularisation

    ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention

    Long-term function of TAVI valves “is excellent”

    ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

    “Telestenting” is possible with robotic PCI

    Edwards’ self-expanding Centera TAVI valve now on European market

    Merit releases Prelude IDeal hydrophilic sheath

    Caristo Diagnostics launched to commercialise new coronary CT image analysis technology

    Biosensors announces enrolment of first patient in REFORM pivotal trial

    Ross procedure “associated with better long-term outcomes” for aortic valve replacement

    TCT 2018: FFRangio may provide a faster and easier approach to physiological assessment

    Neovasc to begin COSIRA-II trial of Reducer for refractory angina

    First patient enrolled in BIOMICS study for CTO-PCI

    Zenition

    Philips launches Zenition mobile C-arm platform

    Five-year results of Gore REDUCE clinical study published

    EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

    Corindus showcasing CorPath GRX system at TCT 2019

    3D printing to support physician training and coronary device testing

    Ancora Heart enrols first patient in the CORCINCH-HF study

    Philips launches Intellispace Cardiovascular image and information management system

    EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic

    Presence of left bundle branch block significantly increases risk of pacemaker implantation after TAVI

    ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia

    EMPAKT CHF trial points to change in assessment acute heart failure patients

    CDRH adjusts working practices with medical device companies to deal with COVID-19

    Abbott receives CE mark for the next-generation Mitraclip

    ESC 2018: British Heart Foundation to provide £30m for innovation in heart disease

    Cardiovascular News’ top 10 most popular news stories of June 2022

    ACC and SVS Join Forces on Single Vascular Registry

    Gore announces encouraging early results for its pulmonary valved conduit

    ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease

    MedAlliance gains CE mark approval for coronary Selution SLR balloon

    AstraZeneca receives EU approval for heart failure drug Forxiga

    CSI recalls Wirion embolic protection device

    Coronary angiography after TAVI with a self-expanding valve is challenging but feasible

    Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

    Patient enrolment in US early feasibility study of Everdur TAVI device initiated

    Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology

    Ron Waksman joins SIS Medical AG advisory board

    Japan and the USA see an increase in PCI procedures

    Fantom Encore launched onto market

    Mavacamten granted Breakthrough Therapy Designation

    CRT 2021: Registry data finds BASILICA has a low coronary artery obstruction rate

    CE mark for PASCAL mitral valve repair system

    ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by 29% in patients with prior myocardial infarction

    Abbott announces CE mark for world’s longest coronary drug-eluting stent

    First implant of Pascal transcatheter mitral valve repair device performed in CLASP IID trial

    Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership

    Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures

    Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool

    Patients with mitral annulus calcification at higher risk of mitral valve dysfunction

    CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT

    TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system

    Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months

    HeartFlow receives national reimbursement approval in Japan

    CE mark for the FEops HEARTguide

    Virtue SEB given breakthrough device designation by FDA

    England’s first COVID-19 lockdown led to a significant drop in PCI procedures

    TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients

    Xeltis announces “promising outcomes” in restorative graft trials following EU financing

    ESC Congress 2020: Society publishes new guidelines on congenital heart disease, non-ST-segment elevation ACS

    ESC 2022: Risk score predicts mortality for AF patients after TAVI

    Eating is no less safe than fasting prior to cardiac catheterisation

    EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis

    ESC 2017: More evidence that supplemental oxygen in normoxic patients with suspected myocardial infarction does not provide benefit

    TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system

    First patient in Japan treated with Impella 5.5 with SmartAssist

    ESH position paper highlights renal denervation as a third option for hypertension management

    PCR London Valves 2019: PARTNER 2 analysis shows Sapien 3 valve as durable as surgical valves at four years

    TCT 2021: Late-breaking trials programme announced

    Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

    St. Jude Medical announces launch of the ViewMate Z intracardiac ultrasound system and ViewFlex Plus ICE catheter

    AI

    US FDA approval for AI TAVI planning software

    COVID-19 “lays the foundation for a digital shift in cardiovascular care”

    PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

    Society of Cardiovascular Computed Tomography to present gold medal award to John Lesser

    Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19

    More randomised trials needed in cardiothoracic surgery, says EACTS president

    CE mark for Watchman FLX left atrial appendage closure device

    Siemens launches Luminos Impulse fluoroscopy system

    ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases

    New trial of Symplicity Spyral approved

    VEST external stent demonstrates low event and disease rates in two prospective trials

    Limited health literacy associated with a higher risk of death in heart failure patients

    TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective

    Medtronic first to receive CE mark for less-invasive HVAD implant procedure

    Partnership to develop training system for complex valve-in-valve procedures

    GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality of life for people with NYHA Class II–IV heart failure

    AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery

    ISET 2018: OPTALYSE PE trial reinforces safety and efficacy of EKOS therapy

    TVT 2019: TAVI is “preferred therapy” for low-risk patients

    Study of next-generation JenaValve device completes enrolment

    EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

    Machine learning enables “clinically important” characterisation of coronary artery disease

    Study documents “surprisingly benign” impact of COVID-19 among cardiac surgery patients

    Opsens files 510(k) submission to US FDA for TAVI guidewire

    STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns

    EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective

    CathWorks FFRangio system receives reimbursement approval in Japan

    First patient in Hong Kong receive treatment with coronary Orbital Atherectomy System

    ACC 2018: Alirocumab reduces cardiovascular events in high-risk patients

    TCT 2016: FDA approve Amplatzer PFO occluder device ahead of first report investigation presentation

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of July 2021

    First patient enrolled in STTAR study of MIA—minimally invasive annuloplasty

    ESC 2023: Siemens unveils Acuson Origin imaging platform

    Survey suggests that cardiology is one of the rudest specialties

    Evolocumab becomes first PCSK9 inhibitor to be approved for use in the USA to prevent myocardial infarction

    New technologies will simplify and shorten aortic surgical procedures while reducing radiation

    Surgical team completes first implant of Aeson bioprosthetic heart in a female patient

    LivaNova launches Perceval Plus sutureless heart valve in Europe

    Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system

    Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin

    Three studies support efficacy of PFO closure for reducing risk of recurrent stroke

    Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

    CMS creates new MS-DRG codes and payments for coronary IVL

    FDA Breakthrough Device Designation for novel heart failure therapy

    UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction

    Endotronix closes expanded series D financing round of US$70 million for Cordella

    Abiomed given green light for RECOVER IV randomised trial

    First European implants of Trilogy TAVI system completed

    iVascular receives CE mark for Navitian microcatheter

    AHA 2020: Sinomed announces positive safety and efficacy data from PIONEER III study

    Urgent TAVI patients more likely to be readmitted than elective cases

    Elsevier announces the launch of Case: Cardiovascular Imaging Case Reports

    Athena Poppas begins ACC presidency

    Less than a third of Americans known that cardiovascular disease is the biggest cause of death

    PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure

    Key learnings from Manta device study to be presented at TCT

    Tendyne receives breakthrough designation for MAC patients

    Court of Dusseldorf grants Alvimedica an injunction against A B Handels GmBH

    Sapien 3 receives expanded FDA indication for valve-in-valve procedures

    Philips launches IntelliSpace Portal 12 with updated cardiology imaging

    Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

    Impella gains a trio of regulatory approvals

    Alvimedica announces CE mark for Cre8 Evo 2mm

    Circulation publishes special edition dedicated to disparities in cardiovascular medicine

    David J Cohen joins CRF as director of clinical and outcomes research

    TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure

    Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine

    Second phase of ASCENT ASD trial begins

    Telemark microcatheter receives US FDA approval

    Morning exercise is the key to a good night’s sleep after heart bypass surgery

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of May 2021

    ControlRad Select imaging system gains FDA market clearance

    Next generation of aortic surgeons need open and endovascular skills

    ESC 2018: Siemens Healthineers showcase Magnetom Sola Cardiovascular Edition

    Funding for Neptune left ventricular assist device

    TAVI may benefit certain heart valve patients, update society guidelines say

    Inspiron sirolimus eluting stent receives CE mark approval

    Scoreflex NC PTCA catheter gains FDA premarket approval

    Acute heart failure patients see mortality risk double with COVID-19

    Corindus receives Japanese PMDA approval for its CorPath GRX system

    COVID-19: “Essential” vs. “non-essential” TAVI procedures can be difficult to determine

    Viagra may prolong life for men with coronary artery disease

    Carag Bioresorbable Septal Occluder approved for US IDE trial

    Randomised trial data supports use of the PleuraFlow system

    FDA grants Breakthrough designation for ECG-based algorithm

    SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”

    Analysis of STEMI patients finds little difference between prasugrel and ticagrelor after PCI

    123...6Page 1 of 6

    Most read

    Features

    Profiles

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date will@bibamedical.com
    Advertising: Hannah Shiels hannah@bibamedical.com


    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: info@bibamedical.com

    Terms and Conditions | Privacy Policy
    Facebook Linkedin Mail X Youtube